Sonoma Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Accounts Receivable

12 Months Ended

Mar. 31, 2023

NOTE 4 – Accounts Receivable

Accounts receivable, net consists of the following:

Schedule of accounts receivable
	March 31,
	2023			2022
Accounts receivable	$	2,588,000		$	2,488,000
Less: discounts, rebates, distributor fees and returns		(16,000	)		(81,000	)
Total accounts receivable, net	$	2,572,000		$	2,407,000